Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years Old

Clinical trial NCT07204457 · RECRUITING

Trial details

NCT number: NCT07204457
Sponsor: EyeGene Inc.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Meningococcal Infections

Start date: 2025-10-15
Primary completion: 2026-09-01
Enrollment: 1123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.